AAAAAA

   
Results: 1-16 |
Results: 16
INHIBITION OF MCF-7RAS TUMOR-GROWTH BY CARBOXYMETHYL BENZYLAMIDE DEXTRAN - BLOCKAGE OF THE PARACRINE EFFECT AND RECEPTOR-BINDING OF TRANSFORMING-GROWTH-FACTOR BETA-1 AND PLATELET-DERIVED GROWTH FACTOR-BB
Authors: BAGHERIYARMAND R KOURBALI Y MORERE JF JOZEFONVICZ J CREPIN M
Citation: R. Bagheriyarmand et al., INHIBITION OF MCF-7RAS TUMOR-GROWTH BY CARBOXYMETHYL BENZYLAMIDE DEXTRAN - BLOCKAGE OF THE PARACRINE EFFECT AND RECEPTOR-BINDING OF TRANSFORMING-GROWTH-FACTOR BETA-1 AND PLATELET-DERIVED GROWTH FACTOR-BB, Cell growth & differentiation, 9(6), 1998, pp. 497-504
INTERIM-REPORT OF PHASE-II STUDY OF PACLITAXEL BIWEEKLY AS RADIOSENSITIZER, AFTER PACLITAXEL (TAXOL(R))-CARBOPLATIN INDUCTION IN STAGE III-IV HEAD AND NECK-CARCINOMA
Authors: BOUILLET T MORERE JF DESPREAUX G AGRANAT P COULON MA PIPERNONEUMANN S BRUNET A BRUNEL P BREAU JL
Citation: T. Bouillet et al., INTERIM-REPORT OF PHASE-II STUDY OF PACLITAXEL BIWEEKLY AS RADIOSENSITIZER, AFTER PACLITAXEL (TAXOL(R))-CARBOPLATIN INDUCTION IN STAGE III-IV HEAD AND NECK-CARCINOMA, Annals of oncology, 9, 1998, pp. 379-379
CISPLATINE (CDDP)-ETOPOSIDE (VP16)-VINORELBINE (VNR) COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY
Authors: COULON MA MORERE JF PIPERNONEUMANN S BREAU JL
Citation: Ma. Coulon et al., CISPLATINE (CDDP)-ETOPOSIDE (VP16)-VINORELBINE (VNR) COMBINATION IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE-II STUDY, Annals of oncology, 9, 1998, pp. 461-461
THE SUPPRESSION OF FIBROBLAST GROWTH-FACTOR-2 FIBROBLAST GROWTH-FACTOR-4-DEPENDENT TUMOR ANGIOGENESIS AND GROWTH BY THE ANTI-GROWTH FACTOR ACTIVITY OF DEXTRAN DERIVATIVE (CMDB7)
Authors: BAGHERIYARMAND R KOURBALI Y MABILAT C MORERE JF MARTIN A LU H SORIA C JOZEFONVICZ J CREPIN M
Citation: R. Bagheriyarmand et al., THE SUPPRESSION OF FIBROBLAST GROWTH-FACTOR-2 FIBROBLAST GROWTH-FACTOR-4-DEPENDENT TUMOR ANGIOGENESIS AND GROWTH BY THE ANTI-GROWTH FACTOR ACTIVITY OF DEXTRAN DERIVATIVE (CMDB7), British Journal of Cancer, 78(1), 1998, pp. 111-118
VINORELBINE AND IFOSFAMIDE FOR UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: MORERE JF PIPERNONEUMANN S BRUNET A BOAZIZ C KOHN M BOUILLET T BREAU JL
Citation: Jf. Morere et al., VINORELBINE AND IFOSFAMIDE FOR UNRESECTABLE NONSMALL CELL LUNG-CANCER, Lung cancer, 18(1), 1997, pp. 95-100
INHIBITION OF HUMAN BREAST EPITHELIAL HBL100 CELL-PROLIFERATION BY A DEXTRAN DERIVATIVE (CMDB7) WITH THE FGF2 AUTOCRINE LOOP (VOL 239, PG 424, 1997)
Authors: BAGHERIYARMAND R LIU JF LEDOUX D MORERE JF CREPIN M
Citation: R. Bagheriyarmand et al., INHIBITION OF HUMAN BREAST EPITHELIAL HBL100 CELL-PROLIFERATION BY A DEXTRAN DERIVATIVE (CMDB7) WITH THE FGF2 AUTOCRINE LOOP (VOL 239, PG 424, 1997), Biochemical and biophysical research communications, 241(3), 1997, pp. 804-804
INHIBITION OF HUMAN BREAST EPITHELIAL HBL100 CELL-PROLIFERATION BY A DEXTRAN DERIVATIVE (CMDB7) WITH THE FGF2 AUTOCRINE LOOP
Authors: BAGHERIYARMAND R LIU JF LEDOUX D MORERE JF CREPIN M
Citation: R. Bagheriyarmand et al., INHIBITION OF HUMAN BREAST EPITHELIAL HBL100 CELL-PROLIFERATION BY A DEXTRAN DERIVATIVE (CMDB7) WITH THE FGF2 AUTOCRINE LOOP, Biochemical and biophysical research communications, 239(2), 1997, pp. 424-428
SOMATOSTATIN RECEPTOR IMAGING IN SMALL-CELL LUNG-CANCER
Authors: BERENGER N MORETTI JL BOAZIZ C VIGNERON N MORERE JF BREAU JL
Citation: N. Berenger et al., SOMATOSTATIN RECEPTOR IMAGING IN SMALL-CELL LUNG-CANCER, European journal of cancer, 32A(8), 1996, pp. 1429-1431
INDUCTION CHEMOTHERAPY (INDCT) AND CONCURRENT BI WEEKLY INFUSION OF 5-FU AND CISPLATIN (CDDP) COMBINED WITH CONCOMITANT CHEST IRRADIATION (CCRT) IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC)
Authors: BREAU JL BOUILLET Z MAZERON JJ MORERE JF PIPERNONEUMAN S BOAZIZ C HADDAD E
Citation: Jl. Breau et al., INDUCTION CHEMOTHERAPY (INDCT) AND CONCURRENT BI WEEKLY INFUSION OF 5-FU AND CISPLATIN (CDDP) COMBINED WITH CONCOMITANT CHEST IRRADIATION (CCRT) IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1089-1089
CAN NUCLEAR-MEDICINE PREDICT RESPONSE TO CHEMOTHERAPY
Authors: MORETTI JL CAGLAR M DURANCORDOBES M MORERE JF
Citation: Jl. Moretti et al., CAN NUCLEAR-MEDICINE PREDICT RESPONSE TO CHEMOTHERAPY, European journal of nuclear medicine, 22(2), 1995, pp. 97-100
SEQUENTIAL FUNCTIONAL IMAGING WITH TC-99M HEXAKIS-2-METHOXYISOBUTYLISONITRILE AND IN-111 OCTREOTIDE - CAN WE PREDICT THE RESPONSE TO CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: MORETTI JL CAGLAR M BOAZIZ C CAILLATVIGNERON N MORERE JF
Citation: Jl. Moretti et al., SEQUENTIAL FUNCTIONAL IMAGING WITH TC-99M HEXAKIS-2-METHOXYISOBUTYLISONITRILE AND IN-111 OCTREOTIDE - CAN WE PREDICT THE RESPONSE TO CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, European journal of nuclear medicine, 22(2), 1995, pp. 177-180
CISPLATIN 5-FLUOROURACIL IN SMALL-CELL LUNG-CANCER - A PHASE-II STUDYIN 109 PATIENTS
Authors: MORERE JF DURAN A TCHERAKIAN F BOAZIZ C VALEYRE D BATTESTI JP BREAU JL ISRAEL L
Citation: Jf. Morere et al., CISPLATIN 5-FLUOROURACIL IN SMALL-CELL LUNG-CANCER - A PHASE-II STUDYIN 109 PATIENTS, Lung cancer, 11(3-4), 1994, pp. 275-281
BONE-MARROW INFILTRATION BY TUMORAL CELLS OR REPLICATION OF PRIMITIVEPRECURSOR CELLS - STIMULATED BY HEMATOPOIETIC GROWTH-FACTOR
Authors: CAILLATVIGNERON N BRUNET A PIPERNONEUMAN S RAPHAEL M MORERE JF BREAU JL MORETTI JL
Citation: N. Caillatvigneron et al., BONE-MARROW INFILTRATION BY TUMORAL CELLS OR REPLICATION OF PRIMITIVEPRECURSOR CELLS - STIMULATED BY HEMATOPOIETIC GROWTH-FACTOR, Blood, 84(10), 1994, pp. 10000580-10000580
EVALUATION OF THE ANTIPROSTAGLANDIN AGENT PIROXICAM IN 87 PATIENTS WITH ADVANCED CANCER
Authors: ISRAEL L BREAU JL MORERE JF BOAZIZ C
Citation: L. Israel et al., EVALUATION OF THE ANTIPROSTAGLANDIN AGENT PIROXICAM IN 87 PATIENTS WITH ADVANCED CANCER, La Semaine des hopitaux de Paris, 69(35), 1993, pp. 1293-1297
UVEAL MELANOMA
Authors: BOAZIZ C MAZERON JJ MORERE JF BREAU JL ISRAEL L
Citation: C. Boaziz et al., UVEAL MELANOMA, Bulletin du cancer, 80(7), 1993, pp. 577-583
RENAL-CELL CARCINOMA - VARIATIONS OF BLOOD LYMPHOCYTE SUBPOPULATIONS UNDER TREATMENT BY INTERFERON-ALPHA-2B AND R-INTERLEUKIN-2
Authors: RAYMOND E BOAZIZ C KOMAROVER H BREAU JL MOLIARD M MORERE JF ISRAEL L
Citation: E. Raymond et al., RENAL-CELL CARCINOMA - VARIATIONS OF BLOOD LYMPHOCYTE SUBPOPULATIONS UNDER TREATMENT BY INTERFERON-ALPHA-2B AND R-INTERLEUKIN-2, Bulletin du cancer, 80(4), 1993, pp. 299-309
Risultati: 1-16 |